je.st
news
Tag: johnson
Johnson & Johnson: Rewarding Patient, Deep Analysis Oriented Investors
2015-10-21 21:10:12| Biotech - Topix.net
Johnson & Johnson, showing it's awareness from a shareholder sentiment standpoint, has approved a $10 billion share buyback program to reward patient and smart investors. I think if you can trust any company currently trading to navigate tough waters while also justifying investor patience and trust it's this one.
Tags: analysis
deep
johnson
patient
Johnson Controls joins White House Roundtable to Reinforce Commitment to Reducing Greenhouse Gas Emissions
2015-10-21 12:31:11| Industrial Newsroom - All News for Today
Company on track to meet $50 million RD product investment that benefits both the environment and building operators MILWAUKEE Johnson Controls today joined a White House roundtable discussion on actions toward a phase down of high global warming potential (GWP) refrigerants. In its first 12 months of a...
Green Streets Cleanup Blitz in the Johnson Creek Watershed
2015-10-20 00:05:30| PortlandOnline
The volunteer-powered event will take place this Saturday, October 24th, from 9:00am to Noon
Tags: green
johnson
creek
streets
Johnson & Johnson's Stelara Succeeds In Phase III Crohn's Disease Trial
2015-10-19 19:30:37| Food - Topix.net
Johnson & Johnson's Stelara was significantly better than placebo at inducing clinical response and remissions in patients with moderate to severe Crohn's disease, according to data from a late stage trial, providing ammunition for a potential expanded approval of the medicine. Stelara, a biotech medicine that blocks inflammation, is approved to treat the skin condition scaly plaque psoriasis and a type of arthritis associated with psoriasis.
Johnson & Johnson: Stelara fares well in Crohn's disease
2015-10-19 16:04:05| Biotech - Topix.net
Johnson & Johnson's immune disorder drug Stelara significantly reduced symptoms of the inflammatory bowel condition Crohn's disease with just one infusion in about half the patients tested, according to the company. The results, released Monday, are the first from multiple late-stage studies - normally the last stage before seeking regulatory approval for Crohn's, which J&J plans to do later this year.
Tags: disease
johnson
fares
crohns
Sites : [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] next »